10May/13

Lilly Halts Drug Development After Failed Trial – Inside INdiana Business (press release)


Dividend.com

Lilly Halts Drug Development After Failed Trial
Inside INdiana Business (press release)
The study failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of relapse following rituximab-based chemotherapy. There were no new safety findings, and the safety data were …
Lilly To Take $30M Charge After Relapse Cancer Drug Disappoints in TrialFox Business
Enzastaurin, Eli Lilly’s Lymphoma Drug Fails In Late-Stage TrialMedical Daily
Lilly Halts Development of Lymphoma Drug After Phase III FailureGenetic Engineering News

all 15 news articles »

09May/13

New tool for identifying powerful HIV antibodies – Science Daily – Science Daily (press release)


Medical Daily

New tool for identifying powerful HIV antibodies – Science Daily
Science Daily (press release)
May 9, 2013 — A team of NIH scientists has developed a new tool to identify broadly neutralizing antibodies (bNAbs) capable of preventing infection by the majority of HIV strains found around the globe, an advance that could help speed HIV vaccine …
NIH Develops New Tool To Search For HIV Antibodies, Could Speed Vaccine …Medical Daily
US researchers develop new tool in HIV vaccine fightFRANCE 24

all 3 news articles »